GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Forward PE Ratio

Kindstar Globalgene Technology (HKSE:09960) Forward PE Ratio : 0.00 (As of May. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Forward PE Ratio?

Kindstar Globalgene Technology's Forward PE Ratio for today is 0.00.

Kindstar Globalgene Technology's PE Ratio without NRI for today is 34.68.

Kindstar Globalgene Technology's PE Ratio for today is 34.68.


Kindstar Globalgene Technology Forward PE Ratio Historical Data

The historical data trend for Kindstar Globalgene Technology's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Forward PE Ratio Chart

Kindstar Globalgene Technology Annual Data
Trend 2021-12 2022-12 2023-12
Forward PE Ratio
40.00 37.17 15.60

Kindstar Globalgene Technology Semi-Annual Data
2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03
Forward PE Ratio 45.25 40.00 22.99 22.83 23.04 37.17 25.32

Competitive Comparison of Kindstar Globalgene Technology's Forward PE Ratio

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's Forward PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Forward PE Ratio falls into.



Kindstar Globalgene Technology Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Kindstar Globalgene Technology  (HKSE:09960) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Kindstar Globalgene Technology Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology (HKSE:09960) Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines